Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice

Norio Horiguchi, Fouad Lafdil, Andrew M. Miller, Ogyi Park, Hua Wang, Mohanraj Rajesh, Partha Mukhopadhyay, Xin Yuan Fu, Pal Pacher, Bin Gao

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Liver injury is associated with inflammation, which is generally believed to accelerate the progression of liver diseases; however, clinical data show that inflammation does not always correlate with hepatocelluar damage in some patients. Investigating the cellular mechanisms underlying these events using an experimental animal model, we show that inflammation may attenuate liver necrosis induced by carbon tetrachloride (CCl4) in myeloid-specific signal transducer and activator of transcription 3 (STAT3) knockout mice. As an important anti-inflammatory signal, conditional deletion of STAT3 in myeloid cells results in markedly enhanced liver inflammation after CCl4 injection. However, these effects are also accompanied by reduced liver necrosis, correlating with elevated serum interleukin-6 (IL-6) and hepatic STAT3 activation. An additional deletion of STAT3 in hepatocytes in myeloid-specific STAT3 knockout mice restored hepatic necrosis but decreased liver inflammation. Conclusion: Inflammation-mediated STAT3 activation attenuates hepatocellular injury induced by CCl4 in myeloid-specific STAT3 knockout mice, suggesting that inflammation associated with a predominance of hepatoprotective cytokines that activate hepatic STAT3 may reduce rather than accelerate hepatocellular damage in patients with chronic liver diseases.

Original languageEnglish
Pages (from-to)1724-1734
Number of pages11
JournalHepatology
Volume51
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

STAT3 Transcription Factor
Gene Knockout Techniques
Carbon Tetrachloride
Myeloid Cells
Knockout Mice
Inflammation
Liver
Necrosis
Transcriptional Activation
Liver Diseases
Wounds and Injuries
Hepatocytes
Interleukin-6
Chronic Disease
Anti-Inflammatory Agents
Animal Models
Cytokines
Injections

ASJC Scopus subject areas

  • Hepatology

Cite this

Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. / Horiguchi, Norio; Lafdil, Fouad; Miller, Andrew M.; Park, Ogyi; Wang, Hua; Rajesh, Mohanraj; Mukhopadhyay, Partha; Fu, Xin Yuan; Pacher, Pal; Gao, Bin.

In: Hepatology, Vol. 51, No. 5, 05.2010, p. 1724-1734.

Research output: Contribution to journalArticle

Horiguchi, Norio ; Lafdil, Fouad ; Miller, Andrew M. ; Park, Ogyi ; Wang, Hua ; Rajesh, Mohanraj ; Mukhopadhyay, Partha ; Fu, Xin Yuan ; Pacher, Pal ; Gao, Bin. / Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. In: Hepatology. 2010 ; Vol. 51, No. 5. pp. 1724-1734.
@article{64fafbd7852c45a3af8eb9de26e9a2b8,
title = "Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice",
abstract = "Liver injury is associated with inflammation, which is generally believed to accelerate the progression of liver diseases; however, clinical data show that inflammation does not always correlate with hepatocelluar damage in some patients. Investigating the cellular mechanisms underlying these events using an experimental animal model, we show that inflammation may attenuate liver necrosis induced by carbon tetrachloride (CCl4) in myeloid-specific signal transducer and activator of transcription 3 (STAT3) knockout mice. As an important anti-inflammatory signal, conditional deletion of STAT3 in myeloid cells results in markedly enhanced liver inflammation after CCl4 injection. However, these effects are also accompanied by reduced liver necrosis, correlating with elevated serum interleukin-6 (IL-6) and hepatic STAT3 activation. An additional deletion of STAT3 in hepatocytes in myeloid-specific STAT3 knockout mice restored hepatic necrosis but decreased liver inflammation. Conclusion: Inflammation-mediated STAT3 activation attenuates hepatocellular injury induced by CCl4 in myeloid-specific STAT3 knockout mice, suggesting that inflammation associated with a predominance of hepatoprotective cytokines that activate hepatic STAT3 may reduce rather than accelerate hepatocellular damage in patients with chronic liver diseases.",
author = "Norio Horiguchi and Fouad Lafdil and Miller, {Andrew M.} and Ogyi Park and Hua Wang and Mohanraj Rajesh and Partha Mukhopadhyay and Fu, {Xin Yuan} and Pal Pacher and Bin Gao",
year = "2010",
month = "5",
doi = "10.1002/hep.23532",
language = "English",
volume = "51",
pages = "1724--1734",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice

AU - Horiguchi, Norio

AU - Lafdil, Fouad

AU - Miller, Andrew M.

AU - Park, Ogyi

AU - Wang, Hua

AU - Rajesh, Mohanraj

AU - Mukhopadhyay, Partha

AU - Fu, Xin Yuan

AU - Pacher, Pal

AU - Gao, Bin

PY - 2010/5

Y1 - 2010/5

N2 - Liver injury is associated with inflammation, which is generally believed to accelerate the progression of liver diseases; however, clinical data show that inflammation does not always correlate with hepatocelluar damage in some patients. Investigating the cellular mechanisms underlying these events using an experimental animal model, we show that inflammation may attenuate liver necrosis induced by carbon tetrachloride (CCl4) in myeloid-specific signal transducer and activator of transcription 3 (STAT3) knockout mice. As an important anti-inflammatory signal, conditional deletion of STAT3 in myeloid cells results in markedly enhanced liver inflammation after CCl4 injection. However, these effects are also accompanied by reduced liver necrosis, correlating with elevated serum interleukin-6 (IL-6) and hepatic STAT3 activation. An additional deletion of STAT3 in hepatocytes in myeloid-specific STAT3 knockout mice restored hepatic necrosis but decreased liver inflammation. Conclusion: Inflammation-mediated STAT3 activation attenuates hepatocellular injury induced by CCl4 in myeloid-specific STAT3 knockout mice, suggesting that inflammation associated with a predominance of hepatoprotective cytokines that activate hepatic STAT3 may reduce rather than accelerate hepatocellular damage in patients with chronic liver diseases.

AB - Liver injury is associated with inflammation, which is generally believed to accelerate the progression of liver diseases; however, clinical data show that inflammation does not always correlate with hepatocelluar damage in some patients. Investigating the cellular mechanisms underlying these events using an experimental animal model, we show that inflammation may attenuate liver necrosis induced by carbon tetrachloride (CCl4) in myeloid-specific signal transducer and activator of transcription 3 (STAT3) knockout mice. As an important anti-inflammatory signal, conditional deletion of STAT3 in myeloid cells results in markedly enhanced liver inflammation after CCl4 injection. However, these effects are also accompanied by reduced liver necrosis, correlating with elevated serum interleukin-6 (IL-6) and hepatic STAT3 activation. An additional deletion of STAT3 in hepatocytes in myeloid-specific STAT3 knockout mice restored hepatic necrosis but decreased liver inflammation. Conclusion: Inflammation-mediated STAT3 activation attenuates hepatocellular injury induced by CCl4 in myeloid-specific STAT3 knockout mice, suggesting that inflammation associated with a predominance of hepatoprotective cytokines that activate hepatic STAT3 may reduce rather than accelerate hepatocellular damage in patients with chronic liver diseases.

UR - http://www.scopus.com/inward/record.url?scp=77951428317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951428317&partnerID=8YFLogxK

U2 - 10.1002/hep.23532

DO - 10.1002/hep.23532

M3 - Article

VL - 51

SP - 1724

EP - 1734

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -